Here's what I am seeing today: speculative buying based on the webinar announcement for a potential pump and dump going into Thursday.
Only thing that will change the SP med-long term is a collab with $ upfront or milestone payments involved.
So worst case scenario is that the HSV-2 Vax is a bomb. Right? In that case, we'd - I hope - see AHZ divest itself of the Immunotherapies division immediately making the company CF+ by a large margin in the next 6 months easy.
If not a bomb then we'd have to see a partnership/collab with the aforementioned up fronts/milestone to justify keep running it.
So we need decisive action on this now. If a CR is proffered to fund the operational costs of the Vax program I will be very very disappointed.
Ann: HSV-2 Phase IIa Results Investor Webinar, page-128
-
- There are more pages in this discussion • 169 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.60 |
Change
-0.100(0.53%) |
Mkt cap ! $357.5M | |||
| Open | High | Low | Value | Volume |
| $18.70 | $18.77 | $18.21 | $664.1K | 35.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $18.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.69 | 53 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |